HHS/FDA
Orders where directed actors are tied to HHS/FDA · 2 in Search.
Roles directed
Orders
2 shown
Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients
This executive order directs the Administration to pursue most-favored-nation prescription drug pricing, requiring pharmaceutical manufacturers to offer U.S. patients prices comparable to other developed nations or face potential rulemaking, importation waivers, antitrust enforcement, export reviews, and FDA approval modifications. It establishes a 30-day deadline for HHS to communicate price targets to drug makers, with escalating measures if progress is not achieved.
Combating Antibiotic-Resistant Bacteria
This executive order establishes a government-wide framework to combat antibiotic-resistant bacteria by creating an interagency task force, a presidential advisory council, and mandating specific actions including antibiotic stewardship programs in healthcare facilities, strengthened surveillance systems, promotion of new drug development, and international cooperation. It sets concrete deadlines for a national action plan and regulatory reviews to address what the CDC identified as at least 23,000 annual U.S. deaths from resistant infections.